Update | Jotup

G1 Therapeutics Provides Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights

Retrieved on:

Wednesday, February 28, 2024

G1 Therapeutics, Breast cancer, Carboplatin, Research, PIN, SCLC, Telephone, Update, J. P. Morgan, DMC, Food, Growth, SACT, G1, Trilaciclib, Hospital, ADC, OS, Conjugation, GAAP, Event, Therapy, Webcast, Patent, Patient, Acceleration, Clinical trial, Survival, Oncology, ITT, Pharmaceutical industry

G1 recognized total revenues of $14.9 million and $82.5 million for the fourth quarter and full year of 2023, respectively.

Key Points:

G1 recognized total revenues of $14.9 million and $82.5 million for the fourth quarter and full year of 2023, respectively.
Operating expenses for the fourth quarter of 2023 were $23.8 million, compared to $41.1 million for the fourth quarter of 2022.
Research and development (R&D) expenses for the fourth quarter of 2023 were $7.4 million, compared to $16.6 million for the fourth quarter of 2022.
The net loss for the fourth quarter of 2023 was $10.9 million, compared to $33.6 million for the fourth quarter of 2022.

Litigation Update - Knightscope Authorized to Serve Notice of Action Against Capybara Research by Public Disclosure and Press Release Pursuant to Court Order

Retrieved on:

Friday, March 1, 2024

Technology, Robotics, Hardware, Security, Form 8-K, Research, Multimedia, District court, Complaint, Action, Court order, Knightscope, ECF, Security (finance), Update

On December 20, 2023, Knightscope, Inc. [Nasdaq: KSCP] (“Knightscope” or the “Company”) filed a federal lawsuit in the United States District Court for the Southern District of New York, Knightscope, Inc. v. Capybara Research et.

Key Points:

On December 20, 2023, Knightscope, Inc. [Nasdaq: KSCP] (“Knightscope” or the “Company”) filed a federal lawsuit in the United States District Court for the Southern District of New York, Knightscope, Inc. v. Capybara Research et.
1:23-cv-11050-DLC (the “Action”) against Capybara Research, Igor Appelboom (“Appelboom,” and together with Capybara Research, the “Capybara Defendants”), and Accretive Capital LLC d/b/a Benzinga.
View the full release here: https://www.businesswire.com/news/home/20240229740998/en/
Litigation Update - Knightscope Authorized to Serve Notice of Action Against Capybara Research by Public Disclosure and Press Release Pursuant to Court Order (Graphic: Business Wire)
The Action alleges that the Capybara Defendants take short positions in publicly traded companies and release fraudulent, disparaging reports in order to drive the company’s stock price down for their own financial benefit.
Pursuant to the Order of The Honorable Denise L. Cote in the United States District Court for the Southern District of New York, entered on January 29, 2024 (ECF 29), in the matter of Knightscope, Inc. v. Capybara Research et.

RBB Bancorp Announces Stock Repurchase Program

Retrieved on:

Thursday, February 29, 2024

RBB Bancorp (NASDAQ: RBB ) and its subsidiaries, Royal Business Bank ("the Bank") and RBB Asset Management Company ("RAM"), collectively referred to herein as "the Company", announced that its Board of Directors has authorized a stock repurchase program.

Key Points:

RBB Bancorp (NASDAQ: RBB ) and its subsidiaries, Royal Business Bank ("the Bank") and RBB Asset Management Company ("RAM"), collectively referred to herein as "the Company", announced that its Board of Directors has authorized a stock repurchase program.
Under the repurchase program, the Company may buy back up to 1,000,000 shares of its common stock, or approximately 5% of its outstanding shares, through March 31, 2026.
The repurchase program does not obligate the Company to purchase any particular number of shares.
RBB Bancorp is a community-based financial holding company headquartered in Los Angeles, California.

Barclays and Blackstone Credit & Insurance Agree to Sale of Credit Card Receivables

Retrieved on:

Tuesday, February 27, 2024

Banking, Professional Services, Finance, Elis James, Barclays, Investment banking, Growth, Sale, Transaction, Prudential regulation, Account, IRB, Infrastructure, PLC, Update, Blackstone Credit, Credit, Insurance, Bank

Barclays PLC ("Barclays") and Blackstone Credit & Insurance (“Blackstone”) today announced that Barclays Bank Delaware ("BBDE") has entered into an agreement with insurance accounts managed by Blackstone’s Asset Based Finance group, to sell approximately US$1.1 billion of currently outstanding credit card receivables (the “Transaction”) in relation to a defined set of Barclays-branded credit card accounts in the United States of America (the “Accounts”).

Key Points:

Barclays PLC ("Barclays") and Blackstone Credit & Insurance (“Blackstone”) today announced that Barclays Bank Delaware ("BBDE") has entered into an agreement with insurance accounts managed by Blackstone’s Asset Based Finance group, to sell approximately US$1.1 billion of currently outstanding credit card receivables (the “Transaction”) in relation to a defined set of Barclays-branded credit card accounts in the United States of America (the “Accounts”).
This is the first in a series of activities Barclays plans to conduct to reduce its risk-weighted assets (RWAs) and create additional lending capacity for BBDE.
As part of the Transaction, BBDE will enter into a long-term strategic forward flow sale and servicing arrangement with Blackstone related to the Accounts.
Barclays Bank PLC will invest into the Transaction alongside Blackstone’s insurance accounts.

Eighth Annual State of the Data Center Industry Report Reveals How Power Design and AI Demand Has Forever Changed the Industry

Retrieved on:

Tuesday, February 20, 2024

AFCOM , the leading membership association for data center professionals, and Data Center World , the leading global conference for data center facilities and IT professionals, today announce the results of the eighth annual State of the Data Center industry report.

Key Points:

AFCOM , the leading membership association for data center professionals, and Data Center World , the leading global conference for data center facilities and IT professionals, today announce the results of the eighth annual State of the Data Center industry report.
The report, which has been a fixture at the annual Data Center World industry conference, continues to capture the relentless pace of change in the data center industry.
As AI requirements grow, there has been a significant surge in demand, with a mounting focus on capacity to meet higher-density data center requirements.
Data Center World 2024 takes place April 15-18 in Washington, D.C. To register to attend Data Center World, click here .

transcosmos starts operations in India. Showcasing its know-how it has developed in Japan and abroad

Retrieved on:

Thursday, March 7, 2024

BANK, BPO, Growth, Update, CX

TOKYO, March 7, 2024 /PRNewswire-PRWeb/ -- transcosmos inc. is delighted to announce that the company has established transcosmos India Private Limited (Headquarters: Bengaluru, the state of Karnataka, India; Managing Director & COO: Susumu Kaieda; transcosmos India), a wholly-owned subsidiary in India. In March 2024, transcosmos opened Bengaluru Center, the first operations center in India. Located in Bengaluru with 300 workstations, the center began offering services for the India domestic market in the same month.

Key Points:

In March 2024, transcosmos opened Bengaluru Center, the first operations center in India.
Located in Bengaluru with 300 workstations, the center began offering services for the India domestic market in the same month.
Now, transcosmos will showcase expertise built in its overseas business operations and offer high-quality services to expand its business in the India market.
transcosmos is a trademark or registered trademark of transcosmos inc. in Japan and other countries.

BRAINBox Solutions to Present Updated Data at Three Leading Conferences from HeadSMART II and NIH-funded Geriatrics Clinical Trials of BRAINBox TBI Concussion Test

Retrieved on:

Monday, March 4, 2024

RICHMOND, Va., March 4, 2024 /PRNewswire/ -- BRAINBox Solutions today announced current and upcoming presentations of clinical trends and data at three leading, upcoming medical conferences from the HeadSMART II pivotal trial in adult patients and the National Institutes of Health (NIH) funded clinical trial in geriatric patients of its BRAINBox TBI™ concussion diagnostic and prognostic test. Concussion is also known as ATE (Acute Traumatic Encephalopathy) or mTBI (mild traumatic brain injury).

Key Points:

The presentation title is, "Biomarker Profiles Distinguish Geriatric Acute TBI from Dementias: Results from the HeadSMARTII Geriatric Feasibility Study.
" The poster title is: "Biomarker Profiles Distinguish Geriatric TBI from Dementias: Results From the HeadSMART Geriatric Feasibility Study."
"These presentations highlight the breadth of clinical data being assembled to evaluate the diagnostic and prognostic potential of the BRAINBox TBI test across a spectrum of age groups.
"These two trials have made substantial progress, as enrollment in both is expanding and, in the case of HeadSMART II, almost completed," said Donna Edmonds, BRAINBox Solutions' CEO.

The Future of Single Chamber ICDs: BIOTRONIK Takes Unprecedented Market Stance with Proprietary DX Technology

Retrieved on:

Monday, February 12, 2024

DX, Page, Journal of Cardiovascular Electrophysiology, ESC, Risk, Atrial fibrillation, ICD, PMID, American College, REACT, Patient, EACTS, Task force, Molina Healthcare, Guideline, Diagnosis, Update, MATRIX, Medical device

"We are very proud that our DX technology provides the only lead available on the market offering both ventricular pacing/defibrillation and atrial monitoring," said Ryan Walters, BIOTRONIK US President.

Key Points:

"We are very proud that our DX technology provides the only lead available on the market offering both ventricular pacing/defibrillation and atrial monitoring," said Ryan Walters, BIOTRONIK US President.
"Due to DX´s ability to provide additional patient and clinical benefits, it became clear to us that we should be using DX technology with every BIOTRONIK single-chamber ICD."
Subclinical atrial fibrillation detection with a floating atrial sensing dipole in single lead implantable cardioverter-defibrillator systems: Results of the SENSE trial.
REACT DX registry: Real world REACTion to atrial high rate episodes detected in implantable cardioverter-defibrillator recipients with a DX lead.

The Crypto Express Platform-wide Update Revolutionizes User Experience

Retrieved on:

Wednesday, February 7, 2024

Crypto, Update, Communication, Language, Video game

Dubai, United Arab Emirates--(Newsfile Corp. - February 7, 2024) - Crypto Express, a platform known for its cryptocurrency trading signals, recently announced a comprehensive update aimed at improving user experience and expanding its functionalities.

Key Points:

Dubai, United Arab Emirates--(Newsfile Corp. - February 7, 2024) - Crypto Express, a platform known for its cryptocurrency trading signals, recently announced a comprehensive update aimed at improving user experience and expanding its functionalities.
Sleek User Interface: The platform now boasts a sleek and modern user interface, meticulously designed to enhance user engagement and ease of navigation.
Fortified Security Measures: Security remains a top priority, and the update includes fortified security measures to protect user data.
Accessibility Enhancements: The team is committed to making the Crypto Express platform accessible to all users, and the update includes various accessibility enhancements.

Zilliz Cloud Ascends to New Heights: A Quantum Leap in Speed, Performance, and Developer Satisfaction with the Ultimate Vector Database Experience

Retrieved on:

Tuesday, January 30, 2024

Cloud, Azure, Blog, GRPC, GCP, AI, Data management, Merge (SQL), Environment, System, Cardinal, Update, Cosine similarity, SOC, Microsoft, Microsoft Azure, API, Access control, RBAC, Health, AWS, TCO, ISO/IEC, Video game

As a fully managed vector database, leveraging the cloud-native open-source Milvus vector database, Zilliz Cloud now redefines the essence of speed, performance, and developer satisfaction.

Key Points:

As a fully managed vector database, leveraging the cloud-native open-source Milvus vector database, Zilliz Cloud now redefines the essence of speed, performance, and developer satisfaction.
Unified Developer Experience: Zilliz Cloud has a Unified Milvus Client, enhancing the developer experience by providing a seamless interface for efficient application development.
Efficient Data Management: Zilliz Cloud offers one-click data migration between Milvus and Zilliz Cloud, facilitating secure and efficient data management for businesses.
Zilliz Cloud remains at the forefront as the industry moves forward, delivering optimal performance, unbeatable speed, and an environment that prioritizes developer satisfaction.